CONFERENCES
ISRAEL NEWS
HEALTH & WELLNESS
WORLD NEWS
MIDDLE EAST
BUSINESS & INNOVATION
OPINION
JP STORE
Login
Login
Subscribe
JPOST DIGITAL LIBRARY
HOME PAGE
BUSINESS & INNOVATION
OPINION
REAL ESTATE LISTINGS
ALIYAH
JERUSALEM POST CONFERENCE
PREMIUM
JP STORE
Categories
ISRAEL NEWS
WORLD NEWS
MIDDLE EAST
ARAB ISRAELI CONFLICT
US POLITICS
DIASPORA
OPINION
PODCAST
JUDAISM
KABBALAH
CHRISTIAN WORLD
HEALTH & WELLNESS
SCIENCE
LAW
ARCHAEOLOGY
OMG
ENVIRONMENT & CLIMATE CHANGE
FOOD & RECIPES
JERUSALEM POST EN ESPANOL
HISTORY
SPONSORED CONTENT
ADVERTISE WITH US
TERMS OF USE
PRIVACY POLICY
CONTACT US
CANCEL SUBSCRIPTION
CUSTOMER SERVICE
ABOUT US
Jerusalem Post
/
Health & Wellness
Israeli novel drug delivery system en route to FDA approval, company says
Prof. Nissim Garti, who founded Lyotropic Delivery Systems (LDS) back in 2013, told The Jerusalem Post that his company has recently signed several new global contracts.
Prof. Nissim Garti.
(photo credit:
Courtesy
)
By
MAAYAN JAFFE-HOFFMAN
JUNE 26, 2021 20:49
Updated:
JUNE 26, 2021 20:50
See more on
Hebrew University of Jerusalem
|
israeli medical technology
|
nanotechnology research
|
israeli innovation
|
FDA - Food and Drug Administration
RECOMMENDED STORIES
Admitting defeat? Why Hamas officials say the terror group 'lost control' of Gaza
JULY 7, 2025
'Security situation has collapsed': Hamas has lost 80% of its control over Gaza Strip
JULY 7, 2025
Reporter's Notebook: 'Post' meets with top Hebron sheikh who wants to pull out of PA
JULY 6, 2025
IDF cyber chief, retired Iran strategy head piloted fighter jets striking Iran
JULY 6, 2025
Hot Opinion
'Time has run out': Netanyahu should not return from Washington without a hostage deal
By
JPOST EDITORIAL
Iran at a crossroads: Intelligence breaches, internal paranoia shake the regime
By
SALEM ALKETBI
Is an Iran nuclear deal still possible after the US-Israel strikes?
By
CHUCK FREILICH
Paying for the 'day after': Who will fund Gaza’s reconstruction?
By
NEVILLE TELLER